Cargando…

Clinical and economic studies of eptifibatide in coronary stenting

Platelet adhesion and aggregation at the site of coronary stenting can have catastrophic clinical and economic consequences. Therefore, effective platelet inhibition is vital during and after percutaneous coronary intervention. Eptifibatide is an intravenous antiplatelet agent that blocks the final...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pasala, Tilak, Sattayaprasert, Prasongchai, Bhat, Pradeep K, Athappan, Ganesh, Gandhi, Sanjay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128842/ https://www.ncbi.nlm.nih.gov/pubmed/25120366 http://dx.doi.org/10.2147/TCRM.S35664

Ejemplares similares

Clinical and economic studies of eptifibatide in coronary stenting [Corrigendum]
Publicado: (2014)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes
por: Shah, Ibrahim, et al.
Publicado: (2010)

How Safe is Eptifibatide during Urgent Carotid Artery Stenting?
por: Allam, Hesham, et al.
Publicado: (2013)

Immediate outcomes of eptifibatide therapy during intracoronary stent implantation
por: Shariati, Hooman, et al.
Publicado: (2016)

Acute Stent Thrombosis Associated with Eptifibatide-Induced Profound Thrombocytopenia
por: Aljundi, Amer, et al.
Publicado: (2020)

Eptifibatide Bolus Dose During Elective Percutaneous Coronary Intervention
por: Doustkami, Hossein, et al.
Publicado: (2018)

Efficacy of intravenous eptifibatide in primary percutaneous coronary intervention patients
por: Jalalian, Rozita, et al.
Publicado: (2021)

Platelet-activating factor enhancement of calcium influx and interleukin-6 expression, but not production, in human microglia
por: Sattayaprasert, Prasongchai, et al.
Publicado: (2005)

Ticagrelor and Eptifibatide Bolus Versus Ticagrelor and Eptifibatide Bolus With 2‐Hour Infusion in High‐Risk Acute Coronary Syndromes Patients Undergoing Early Percutaneous Coronary Intervention
por: Marian, Moazez J., et al.
Publicado: (2017)

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]
Publicado: (2014)

Low voltage‐guided ablation of posterior wall improves 5‐year arrhythmia‐free survival in persistent atrial fibrillation
por: Cutler, Michael J., et al.
Publicado: (2022)

Eptifibatide, an Older Therapeutic Peptide with New Indications: From Clinical Pharmacology to Everyday Clinical Practice
por: Tonin, Gašper, et al.
Publicado: (2023)

Profound thrombocytopenia after primary exposure to eptifibatide
por: Norgard, Nicholas B, et al.
Publicado: (2010)

A rare case of eptifibatide-induced thrombocytopenia
por: Kamar, Khalil, et al.
Publicado: (2021)

Optimal duration of dual antiplatelet therapy after drug eluting stent implantation: a network meta-analysis
por: Gajulapalli, Rama Dilip, et al.
Publicado: (2017)

Assessment of Eptifibatide Dosing in Renal Impairment Before and After In-Service Education Provided by Pharmacists
por: Donovan, Jennifer L., et al.
Publicado: (2007)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Acute Severe Thrombocytopenia Occurring After Administration of Eptifibatide Postpones Emergent Coronary Artery Surgery
por: Boettcher, Brent T., et al.
Publicado: (2016)

Tibial bypass salvage with eptifibatide in a patient with thrombocythemia
por: Byrne, John, et al.
Publicado: (2015)

Eptifibatide-induced acute profound thrombocytopenia: a case report
por: Graidis, Christos, et al.
Publicado: (2014)

Eptifibatide-induced acute profound thrombocytopenia: A case report
por: Alamin, Mohammed A., et al.
Publicado: (2022)

Adipogenic Signaling Promotes Arrhythmia Substrates before Structural Abnormalities in TMEM43 ARVC
por: Vasireddi, Sunil K., et al.
Publicado: (2022)

Comparing efficacy of receiving different dosages of eptifibatide in bleeding after percutaneous coronary intervention in patients with myocardial infarction
por: Shemirani, Hasan, et al.
Publicado: (2019)

Acute Profound Thrombocytopenia Induced by Eptifibatide Causing Diffuse Alveolar Hemorrhage
por: Byrd, Gregory, et al.
Publicado: (2021)

The Pharmacological Effects of Silver Nanoparticles Functionalized with Eptifibatide on Platelets and Endothelial Cells
por: Hajtuch, Justyna, et al.
Publicado: (2022)

Corticosteroid therapy for primary treatment of Kawasaki disease – weight of evidence: a meta-analysis and systematic review of the literature
por: Athappan, Ganesh, et al.
Publicado: (2009)

RGD-Modified Nano-Liposomes Encapsulated Eptifibatide with Proper Hemocompatibility and Cytotoxicity Effect
por: Bardania, Hassan, et al.
Publicado: (2019)

Impact of maintenance dose of eptifibatide in patients with ST-segment elevation myocardial infarction who underwent primary percutaneous coronary intervention
por: Jalalian, Rozita, et al.
Publicado: (2023)

Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin‐Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial
por: Marian, Moazez J., et al.
Publicado: (2019)

Treatment of progressive ischemic stroke with low‑dose eptifibatide: A retrospective case‑control study
por: Luo, Long, et al.
Publicado: (2022)

Comparison between Intracoronary Abciximab and Intravenous Eptifibatide Administration during Primary Percutaneous Coronary Intervention of Acute ST-Segment Elevation Myocardial Infarction
por: Namazi, Mohammad Hasan, et al.
Publicado: (2013)

Local Intracoronary Eptifibatide versus Mechanical Aspiration in Patients with Acute ST-Elevation Myocardial Infarction
por: Hamza, Mohamed A., et al.
Publicado: (2014)

Early recovery of microvascular perfusion induced by t-PA in combination with abciximab or eptifibatide during postischemic reperfusion
por: Bertuglia, Silva, et al.
Publicado: (2002)

Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis
por: Rana, Ameena, et al.
Publicado: (2022)

Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure
por: Gori, Tommaso
Publicado: (2021)

Biocompatibility of Coronary Stents
por: Jeewandara, Thamarasee M., et al.
Publicado: (2014)

Intracoronary Eptifibatide During Primary Percutaneous Coronary Intervention in Early Versus Late Presenters with ST Segment Elevation Myocardial Infarction: A Randomized Trial
por: Elbadawi, Ayman, et al.
Publicado: (2016)

Eptifibatide-Induced Severe Thrombocytopenia After ST-Elevation Myocardial Infarction (STEMI): A Case Report
por: Gheith, Zaid, et al.
Publicado: (2022)

Rescue Stenting for Refractory Large Vessel Occlusions in the Thrombectomy Era: Intracranial Use of Coronary Stents in Low-mid Economic Settings
por: Sajja, Kalyan Chakravarthy, et al.
Publicado: (2022)

Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients
por: Rathod, KS, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_02s1q7uhq06hfdbh6qoh3ce5hr